OÜ InterVacTechnology
Estonia EE-MF-000001021 Last updated 17 Sep 2026
Is this your brand? Sign in to claim this brand
- Devices
- 1
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Lind-Vac Ref AE1102
About
On the basis of InterVacTechnology production technology, the innovative test tube for diagnosing occult diabetes in pregnant women has been developed and patented. Owing to scientific developments and an innovative attitude of the staff, the factory has managed to achieve very good results, which are going to be really helpful in terms of improving the quality of laboratory diagnostics.
What OÜ InterVacTechnology makes
OÜ InterVacTechnology produces the Lind-Vac, a test tube designed for diagnosing occult diabetes in pregnant women.
The Lind-Vac is classified as an IVD General device and is listed in the EU’s eudamed registry. The company is based in Estonia.
Frequently asked questions
What types of medical devices does OÜ InterVacTechnology manufacture?
OÜ InterVacTechnology specializes in in vitro diagnostic (IVD) devices. Specifically, they produce the Lind-Vac, an innovative test tube designed for diagnosing occult diabetes in pregnant women. This device falls under the IVD General category, meaning it is intended for general diagnostic use in laboratories.
Where is OÜ InterVacTechnology based?
OÜ InterVacTechnology is based in Estonia (EE). The company’s location is relevant for regulatory compliance, as it operates within the European Union’s medical device framework, including registries like eudamed.
Are OÜ InterVacTechnology’s devices listed in any regulatory registries?
Yes, the Lind-Vac test tube produced by OÜ InterVacTechnology is listed in the EU’s eudamed registry. This registry is the official database for medical devices in the European Economic Area, ensuring transparency and traceability of devices under the IVD Regulation.
How are OÜ InterVacTechnology’s devices classified under EU regulations?
The Lind-Vac test tube is classified as an IVD General device. This classification is determined by its intended use—diagnosing occult diabetes in pregnant women—without posing significant risks. IVD General devices are subject to basic regulatory requirements but do not require the same stringent scrutiny as higher-risk devices.
Information
- Country
- Estonia
- Address
- Kadastiku 57, Narva, Estonia
- Website
- www.intervactechnology.com
- facebook.com/intervactechnology
- [email protected]
- Phone
- +372 3571007
- PRRC contact
- Irina Korotkova
- EUDAMED SRN
- EE-MF-000001021